146 related articles for article (PubMed ID: 9099979)
21. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
23. A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation.
Fairhead M; Kelly SM; van der Walle CF
Biochem Biophys Res Commun; 2008 Feb; 366(3):862-7. PubMed ID: 18086562
[TBL] [Abstract][Full Text] [Related]
24. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
[TBL] [Abstract][Full Text] [Related]
25. Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.
Weber E; Günther D; Laube F; Wiederanders B; Kirschke H
J Cancer Res Clin Oncol; 1994; 120(9):564-7. PubMed ID: 8045924
[TBL] [Abstract][Full Text] [Related]
26. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
[TBL] [Abstract][Full Text] [Related]
27. Expression of cathepsins in dermal fibrous tumors: an immunohistochemical study.
Thewes M; Engst R; Boeck K; Ring J
Eur J Dermatol; 1998 Mar; 8(2):86-9. PubMed ID: 9649659
[TBL] [Abstract][Full Text] [Related]
28. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.
Dodds RA; Connor JR; Drake FH; Gowen M
Arthritis Rheum; 1999 Aug; 42(8):1588-93. PubMed ID: 10446855
[TBL] [Abstract][Full Text] [Related]
29. Ethanol consumption alters trafficking of lysosomal enzymes and affects the processing of procathepsin L in rat liver.
Kharbanda KK; McVicker DL; Zetterman RK; Donohue TM
Biochim Biophys Acta; 1996 Aug; 1291(1):45-52. PubMed ID: 8781524
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
[TBL] [Abstract][Full Text] [Related]
31. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
32. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
Hantschmann P; Beysiegel S; Kurzl R
J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
[TBL] [Abstract][Full Text] [Related]
33. Involvement of carboxy-terminal amino acids in secretion of human lysosomal protease cathepsin L.
Chauhan SS; Ray D; Kane SE; Willingham MC; Gottesman MM
Biochemistry; 1998 Jun; 37(23):8584-94. PubMed ID: 9622510
[TBL] [Abstract][Full Text] [Related]
34. Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression.
Troy AM; Sheahan K; Mulcahy HE; Duffy MJ; Hyland JM; O'Donoghue DP
Eur J Cancer; 2004 Jul; 40(10):1610-6. PubMed ID: 15196548
[TBL] [Abstract][Full Text] [Related]
35. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
36. Multiple processing of procathepsin L to cathepsin L in vivo.
Ishidoh K; Saido TC; Kawashima S; Hirose M; Watanabe S; Sato N; Kominami E
Biochem Biophys Res Commun; 1998 Nov; 252(1):202-7. PubMed ID: 9813170
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of procathepsin L, a self-processing zymogen of guinea pig spermatozoa that acts on a cathepsin D assay substrate.
McDonald JK; Emerick JM
Arch Biochem Biophys; 1995 Nov; 323(2):409-22. PubMed ID: 7487106
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney.
Kirschke H; Clausen T; Göhring B; Günther D; Heucke E; Laube F; Löwe E; Neef H; Papesch H; Peinze S; Plehn G; Rebmann U; Rinne A; Rüdrich R; Weber E
J Cancer Res Clin Oncol; 1997; 123(7):402-6. PubMed ID: 9260593
[TBL] [Abstract][Full Text] [Related]
39. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro.
Nishimura Y; Kawabata T; Kato K
Arch Biochem Biophys; 1988 Feb; 261(1):64-71. PubMed ID: 3341779
[TBL] [Abstract][Full Text] [Related]
40. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
Jin Z; Lahat G; Korchin B; Nguyen T; Zhu QS; Wang X; Lazar AJ; Trent J; Pollock RE; Lev D
Clin Cancer Res; 2008 Aug; 14(16):5033-42. PubMed ID: 18698021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
